Loading company…
PharmaEste develops TRP channel therapeutics for several conditions.
Founded in 2003, PharmaEste is a biopharmaceutical company focused on discovering and developing transient receptor potential (TRP) channel therapeutics. Its research targets neuropathic pain, overactive bladder, and other TRP-mediated diseases. The company is based in Italy and is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in